Dr. Ebrahim Abdelrazzak, MD

Dr. Abdelrazzak practices at Mid-Michigan Orthopaedics in Owosso, Michigan.

Dr. Abdelrazzak's NPI, 1215458922, was assigned on July 3, 2017. Dr. Abdelrazzak graduated from American University of Antigua College of Medicine in 2017. Dr. Abdelrazzak's Michigan license number on file is 4301500822.

Dr. Abdelrazzak's primary practice is Mid-Michigan Orthopaedics, at 113 E Williams St, Owosso, MI 48867 in Shiawassee County. The practice phone is (989) 725-6101.

Dr. Abdelrazzak's primary practice is Mid-Michigan Orthopaedics in Owosso, Michigan. Dr. Abdelrazzak is also affiliated with Memorial Healthcare. The medical group on file is Sound Physicians. Dmand AI also links Dr. Abdelrazzak to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelrazzak practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Abdelrazzak's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Abdelrazzak is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Abdelrazzak has a license on file in Michigan.

Dmand AI lists kidney failure, sepsis and stroke among the conditions Dr. Abdelrazzak treats.

CMS data shows 187 Medicare services from Dr. Abdelrazzak across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $19,195 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Dr. Abdelrazzak in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelrazzak's median patient age at 61, with 53% women.

In 2024, Dr. Abdelrazzak wrote 82 Medicare Part D claims for 42 patients. 45% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $10,612 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

Dr. Abdelrazzak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdelrazzak as offering telehealth.

Dmand AI links 1 paper to Dr. Abdelrazzak in 2018. Dr. Abdelrazzak's most frequent co-authors are Juan Jose Gonzalez, MD and Kavitha D. Kesari, MD.

CMS Open Payments shows 159 general payments to Dr. Abdelrazzak from 27 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 86% of the total. GlaxoSmithKline, LLC. paid the most, $775.

Dr. Abdelrazzak graduated from American University of Antigua College of Medicine in 2017.

Dr. Abdelrazzak is in network with 16 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.